Janus Henderson Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246M Sell
2,835,816
-278,342
-9% -$26.7M 0.12% 171
2025
Q4
$299M Sell
3,114,158
-437,994
-12% -$42.5M 0.13% 151
2025
Q3
$338M Sell
3,552,152
-224,493
-6% -$20.6M 0.15% 127
2025
Q2
$329M Sell
3,776,645
-844,135
-18% -$71.6M 0.16% 134
2025
Q1
$405M Buy
4,620,780
+743,248
+19% +$66.5M 0.22% 106
2024
Q4
$310M Buy
3,877,532
+26,618
+0.7% +$2.3M 0.16% 145
2024
Q3
$347M Buy
3,850,914
+1,420,263
+58% +$119M 0.18% 132
2024
Q2
$191M Sell
2,430,651
-1,056,843
-30% -$86.6M 0.1% 176
2024
Q1
$304M Sell
3,487,494
-14,162
-0.4% -$1.21M 0.17% 140
2023
Q4
$289M Sell
3,501,656
-231,038
-6% -$17.6M 0.17% 138
2023
Q3
$292M Buy
3,732,694
+792,937
+27% +$66.4M 0.19% 131
2023
Q2
$259M Sell
2,939,757
-33,828
-1% -$2.91M 0.16% 146
2023
Q1
$240M Sell
2,973,585
-1,080,954
-27% -$88.1M 0.16% 147
2022
Q4
$315M Sell
4,054,539
-3,516,483
-46% -$285M 0.23% 116
2022
Q3
$611M Buy
7,571,022
+3,649,943
+93% +$328M 0.23% 114
2022
Q2
$352M Sell
3,921,079
-764,870
-16% -$77.5M 0.24% 112
2022
Q1
$520M Sell
4,685,949
-564,170
-11% -$59.6M 0.25% 92
2021
Q4
$543M Sell
5,250,119
-1,611,232
-23% -$187M 0.23% 107
2021
Q3
$860M Sell
6,861,351
-320,268
-4% -$41.5M 0.38% 58
2021
Q2
$891M Sell
7,181,619
-228,131
-3% -$28.6M 0.38% 57
2021
Q1
$875M Sell
7,409,750
-290,063
-4% -$34M 0.4% 54
2020
Q4
$902M Buy
7,699,813
+477,533
+7% +$52.6M 0.42% 53
2020
Q3
$750M Buy
7,222,280
+2,378,463
+49% +$239M 0.39% 50
2020
Q2
$444M Buy
4,843,817
+398,438
+9% +$38.2M 0.25% 93
2020
Q1
$401M Sell
4,445,379
-182,982
-4% -$19.5M 0.28% 83
2019
Q4
$525M Buy
4,628,361
+56,486
+1% +$6.2M 0.27% 92
2019
Q3
$497M Buy
+4,571,875
New +$477M 0.27% 88
2018
Q1
Sell
-7,327,699
Closed -$592M 1376
2017
Q4
$592M Sell
7,327,699
-129,663
-2% -$10.4M 0.36% 62
2017
Q3
$580M Buy
+7,457,362
New +$619M 0.37% 58
2017
Q1
Sell
-183,577
Closed -$13.1M 851
2016
Q4
$13.1M Buy
183,577
+16,281
+10% +$1.28M 0.1% 245
2016
Q3
$14.5M Sell
167,296
-4,597
-3% -$401K 0.11% 233
2016
Q2
$14.9M Buy
+171,893
New +$13.9M 0.12% 206
2015
Q1
Sell
-139,299
Closed -$10.1M 851
2014
Q4
$10.1M Hold
139,299
0.07% 285
2014
Q3
$8.63M Sell
139,299
-8,463
-6% -$538K 0.08% 220
2014
Q2
$9.42M Sell
147,762
-4,880
-3% -$296K 0.09% 216
2014
Q1
$9.39M Buy
152,642
+28,616
+23% +$1.67M 0.09% 213
2013
Q4
$7.12M Hold
124,026
0.07% 242
2013
Q3
$6.61M Buy
124,026
+4,528
+4% +$244K 0.07% 236
2013
Q2
$6.22M Buy
+119,498
New +$5.91M 0.07% 238

Other funds holding MDT

Janus Henderson Group's MDT Position: Q1 2026 in Review

Janus Henderson Group reduced its Medtronic (MDT) stake by 8.9% in Q1 2026, selling an estimated $26.7M and leaving 2,835,816 shares worth $246M. The position accounts for 0.12% of the portfolio, ranked #171.

Janus Henderson Group first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $902M in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Janus Henderson Group held 2,835,816 shares of Medtronic worth $246M as of Q1 2026.
  • Janus Henderson Group sold 278,342 Medtronic shares in Q1 2026, an estimated $26.7M.
  • Medtronic made up 0.12% of Janus Henderson Group's portfolio in Q1 2026, its #171 holding.
  • Janus Henderson Group first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
  • Janus Henderson Group's Medtronic position peaked at $902M in Q4 2020.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.